FUNGI-RID - LIQ 10% 10 %
UNDECYLENIC ACID : 10 % · DIN 02222736 · TRIPOD FAMILY FOOT CARE CENTRES INC.
Health Canada status: CANCELLED POST MARKET
What is FUNGI-RID - LIQ 10%?
FUNGI-RID - LIQ 10% 10 % contains UNDECYLENIC ACID : 10 %. It is listed in the Health Canada Drug Product Database under DIN 02222736, held by TRIPOD FAMILY FOOT CARE CENTRES INC., supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Dec-2004. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02222736 |
|---|---|
| Brand name | FUNGI-RID - LIQ 10% |
| Generic / active ingredient | UNDECYLENIC ACID : 10 % |
| Manufacturer | TRIPOD FAMILY FOOT CARE CENTRES INC. |
| Strength | 10 % |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AE04 UNDECYLENIC ACID |
| AHFS class | 84:04.08.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Dec-2004 |
| Original market date | 1996-08-30 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D01AE04 UNDECYLENIC ACID. 0 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CRUEX ANTIFUNGAL CREAM | 3 % | CREAM | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021838 |
| CRUEX MEDICATED PWR 10% | 10 % | POWDER | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021854 |
| CRUEX MEDICATED SPRAY POWDER | 2 % | POWDER ; AEROSOL | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021846 |
| DESENEX ANTIFUNGAL POWDER | 20 % | POWDER | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02021862 |
| DESENEX MEDICATED SPRAY-ON POWDER | 20 % | AEROSOL ; POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02021900 |
| FOOT AND BODY POWDER | 908 G / 91.7 Kg | POWDER | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240605 |
| FOOT SPRAY WITH POWDER | .35 % | AEROSOL | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240656 |
| FUNGAL FOOT SPRAY 0.1% | .1 % | AEROSOL | MUELLER SPORTS MEDICINE, INC. | CANCELLED POST MARKET | DIN 00240664 |
| ZINC UNDECYLENATE | 2 % | POWDER | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00595926 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.